{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/precision-medicine-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage",
"url": "https://www.fortrea.com/insights/precision-medicine-peer-reviewed-journal-articles-featuring-fortrea-oncologists",
"name": "Precision medicine: Peer-reviewed journal articles featuring Fortrea oncologists",
"description": "This Fortrea infosheet explores how oncology clinical development is evolving through precision medicine in oncology, biomarker-driven research, and modern cancer drug development strategies. The content focuses on scientific and clinical perspectives related to oncology biomarkers, molecular oncology profiling, personalized cancer treatment approaches, and biomarker-led clinical trials within precision oncology research environments. The infosheet highlights how targeted cancer therapies and oncology evidence generation are increasingly shaping clinical decision-making and development strategies across evolving oncology programs. Fortrea oncologists discuss ongoing advancements in cancer drug development, precision oncology research, and biomarker integration designed to support individualized therapeutic approaches and future oncology innovation. By integrating oncology evidence generation with precision medicine research and biomarker-focused clinical development strategies, the infosheet provides insights into current trends influencing oncology clinical development and personalized cancer treatment."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Precision medicine: Peer-reviewed journal articles featuring Fortrea oncologists",
"item": "https://www.fortrea.com/insights/precision-medicine-peer-reviewed-journal-articles-featuring-fortrea-oncologists"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/precision-medicine-peer-reviewed-journal-articles-featuring-fortrea-oncologists#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/precision-medicine-peer-reviewed-journal-articles-featuring-fortrea-oncologists#webpage"
},
"headline": "Advancing Oncology Clinical Development Through Precision Medicine and Biomarker Research | Fortrea Infosheet",
"description": "This Fortrea infosheet explores how oncology clinical development is evolving through precision medicine in oncology, biomarker-driven research, and modern cancer drug development strategies. The content focuses on scientific and clinical perspectives related to oncology biomarkers, molecular oncology profiling, personalized cancer treatment approaches, and biomarker-led clinical trials within precision oncology research environments. The infosheet highlights how targeted cancer therapies and oncology evidence generation are increasingly shaping clinical decision-making and development strategies across evolving oncology programs. Fortrea oncologists discuss ongoing advancements in cancer drug development, precision oncology research, and biomarker integration designed to support individualized therapeutic approaches and future oncology innovation. By integrating oncology evidence generation with precision medicine research and biomarker-focused clinical development strategies, the infosheet provides insights into current trends influencing oncology clinical development and personalized cancer treatment.",
"genre": "Info Sheet",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-07-11",
"dateModified": "2025-07-11",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/fortrea-oncologists-precision-medicine-publications-10-04-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}